The first recommendation came from a podcast host you actually respect. The second came from a fitness creator whose advice had checked out before. By the third or fourth time someone you follow mentioned AG1, the pattern started doing what patterns do — it began to feel like evidence.
Seventy-five ingredients. A price tag that signals premium. A wall of endorsements from people whose judgment you trust on nearly everything else. At $79 a month, the product has already made its case before you ever look at a study — because until now, nobody you listened to ever mentioned one.
Is a Greens Powder Like AG1 Worth the Money?
AG1's own clinical trial — funded by the company, with AG1 employees as co-authors — found no significant improvement on any patient-reported outcome in 30 healthy adults over four weeks. The three supplements with the strongest replicated evidence (creatine, protein powder, caffeine) cost $15 to $25 a month combined, compared to AG1's $79.
— La Monica et al. 2024 · Journal of the International Society of Sports Nutrition · n=30
AG1 has one completed clinical trial. The company funded it. Two of the study's authors are AG1 employees. They chose the population — healthy adults, no existing gut issues, no chronic conditions — and they chose the timeline. Under those conditions, designed to give the product its best possible showing, the trial produced no significant improvement on any outcome the participants could feel.
The one trend AG1 highlights — a digestive quality-of-life score that improved more in the supplement group — never crossed the threshold for statistical significance. The probiotic strains the researchers found enriched in the gut were the same strains already in the product. The study's own authors acknowledged this was not a surprise. The product's ingredients survived the trip through the digestive system. That is expected behavior, not a therapeutic result.
AG1 clearly contains real ingredients — the question the search bar is actually asking is whether $79 a month buys a health benefit that cheaper alternatives cannot.
The three supplements carrying the most replicated research in the fitness-nutrition evidence base — creatine, protein powder, and caffeine — cost roughly $15 to $25 a month combined. Creatine alone, at around ten cents a day, sits behind more than 140 randomized controlled trials. AG1 sits behind one, and that one found nothing significant.
AG1
$79/month · 1 clinical trial · no significant outcomes
EVIDENCE-BACKED STACK
$15–25/month · 338+ studies · replicated benefits
The arithmetic is difficult to unsee. The supplement market's pricing structure inverts its evidence base: the cheapest products carry the deepest research, and the most expensive carry the thinnest. AG1 follows that pattern exactly — a product whose price reflects the cost of reaching every podcast and YouTube channel you subscribe to, rather than the cost of proving it works.
One study, thirty participants, four weeks, industry-funded, and no significant outcomes. That is the full clinical record. The endorsements were real. The evidence underneath them was thinner than you assumed it would be.
The decision framework that matters for every supplement on your shelf starts with one count: how many independent, replicated studies found a measurable benefit — and at what price. By that measure, AG1's own trial already delivered the verdict: nothing significant. The full evidence ranking of what actually works runs through every supplement people take for muscle and performance, sorted by what the combined research shows — and the order contradicts every price tag on the shelf.
If the supplements backed by the deepest research are also the cheapest, the more useful question moves past whether any single product is worth the premium. It becomes whether the entire pricing model you have been using to judge quality — expensive means effective — ever held up at all. The multivitamin evidence confirms the pattern through entirely different research.